Tudtud, Maricel .

HRN: 21-02-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2025
AMPICILLIN 1GM (VIAL)
05/26/2025
06/01/2025
IV
2g
Q6
G8P6(6016) 40 5/7 Weeks AOG By Late UTZ; PROM X 5 Hrs
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines